Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole) and Alcohol / Food Interactions
There are 2 alcohol/food/lifestyle interactions with Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole) which include:
oxytetracycline ↔ multivitamins with minerals
Moderate Drug Interaction
Iron can bind to oxytetracycline in the gastrointestinal tract, which may prevent their absorption into the bloodstream and possibly reduce their effectiveness. To avoid or minimize the interaction, iron-containing medications and oxytetracycline should preferably be taken at least three hours apart in most cases. Talk to your doctor if you have any questions or concerns, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
oxytetracycline ↔ food
Moderate Food Interaction
Consumer information for this interaction is not currently available.
ADJUST DOSING INTERVAL: Administration with food, particularly dairy products, significantly reduces tetracycline absorption. The calcium content of these foods forms nonabsorbable chelates with tetracycline.
MANAGEMENT: Tetracycline should be administered one hour before or two hours after meals.
References
- "Product Information. Achromycin (tetracycline)." Lederle Laboratories, Wayne, NJ.
- "Product Information. Declomycin (demeclocycline)." Lederle Laboratories, Wayne, NJ.
Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole) drug Interactions
There are 382 drug interactions with Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole)
Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole) disease Interactions
There are 9 disease interactions with Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole) which include:
- G-6-Pd Deficiency
- Hepatitis
- Renal Dysfunction
- Hematologic Toxicity
- Colitis
- Hemodialysis
- Hepatotoxicity
- Renal Dysfunction
- Esophageal Irritation
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
